Substance / Medication

Losartan potassium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
[Jinshuibao capsule combined losartan potassium intervened early renal damage of hypertension patients of yin and yang deficiency: a clinical research].
Zhang Cheng-Qiu, Yin Ji-Qing, Xin Qing et al. · Zhongguo Zhong Xi Yi Jie He Za Zhi · 2013
PMID: 23980348RCT
Comparative Efficacy and Safety of Amlodipine and Losartan Potassium in Essential Hypertension in a Tertiary Hospital of Bangladesh.
Shimu R N, Majumder S, Tarannum F et al. · Mymensingh Med J · 2024
PMID: 38557512Observational
The association between losartan potassium prescription and postoperative outcomes following total knee arthroplasty: A TriNetX analysis.
Rana Parimal, Brennan Jane, Johnson Andrea et al. · Orthop Traumatol Surg Res · 2024
PMID: 38428487Observational
Design, Preparation and evaluation of various parameters of controlled release matrices of losartan potassium using polymers combination.
Khan Kamran Ahmad, Khan Gul Majid, Shah Kifayat Ullah et al. · Pak J Pharm Sci · 2020
PMID: 33832895Observational
Simultaneous Determination of Hydrochlorothiazide and Losartan Potassium in Osmotic Pump Tablets by Microemulsion Liquid Chromatography.
Li Liangxing, Lai Caiyun, Xuan Xueyi et al. · J Chromatogr Sci · 2016
PMID: 27334292Observational
Efficacy/safety of olmesartan medoxomil versus losartan potassium in patients by stage 1 or 2 hypertension.
Flack John M, Graff Alan, Li Wei et al. · Postgrad Med · 2012
PMID: 22691900Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Losartan potassium (substance)
SNOMED CT
108582002
UMLS CUI
C0700492

Clinical Data

This intervention maps to 11 entities in the Ltrl knowledge graph.

4
Conditions
4
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.